PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsPyridoxal
Pyridoxal
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
338 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
TuberculosisD014376EFO_0000774A15-A19313135939
Hiv infectionsD015658EFO_0000764B201264518
AnemiaD000740EFO_0004272D64.9—1121317
SyndromeD013577———231712
VomitingD014839—R11.1—152310
NauseaD009325—R11.01—32410
InflammationD007249MP_0001845—2——169
MalnutritionD044342EFO_0008572E40-E46—11169
Iron deficienciesD000090463—E61.1———189
Peripheral nervous system diseasesD010523—G64—11248
Show 54 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pulmonary tuberculosisD014397EFO_1000049A15154—110
InfectionsD007239EFO_0000544———4—37
Hand-foot syndromeD060831EFO_1001893———4—26
Breast neoplasmsD001943EFO_0003869C50—13—26
HivD006678—O98.7—23——5
Acquired immunodeficiency syndromeD000163EFO_0000765B20——2—35
Myocardial ischemiaD017202EFO_1001375I20-I25—32——5
Colorectal neoplasmsD015179——133——5
IschemiaD007511EFO_0000556—222——5
PregnancyD011247EFO_0002950Z33.11—2—25
Show 62 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———32——27
Type 2 diabetes mellitusD003924EFO_0001360E11—3——25
DepressionD003863—F33.911——35
LymphomaD008223—C85.934———4
Heart diseasesD006331EFO_0003777I51.9—2——13
HypertensionD006973EFO_0000537I1011——13
Autism spectrum disorderD000067877—F84.0—1——23
Venous insufficiencyD014689———2———2
Peripheral arterial diseaseD058729EFO_0004265—21———2
MetabolismD008660GO_0008152——1——12
Show 35 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cognitive dysfunctionD060825—G31.841———23
Heart rateD006339EFO_0004326—1————1
Biological availabilityD001682——1————1
PapilledemaD010211EFO_1001074H35.811————1
Non-small-cell lung carcinomaD002289——1————1
HyperlipidemiasD006949EFO_0003774E78.51————1
Insulin resistanceD007333EFO_0002614E88.8191————1
HyperphagiaD006963—R63.21————1
Sedentary behaviorD057185——1————1
PainD010146EFO_0003843R521————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfertilityD007246EFO_0000545—————44
DiarrheaD003967—R19.7————44
Parkinson diseaseD010300EFO_0002508G20————44
AnxietyD001007EFO_0005230F41.1————33
Male infertilityD007248EFO_0004248N46————33
CognitionD003071EFO_0003925—————33
Autistic disorderD001321EFO_0003758F84.0————33
HypercholesterolemiaD006937——————33
Immunologic deficiency syndromesD007153—D84.9————33
Weight lossD015431——————33
Show 110 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
205 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use